fluorodeoxyglucose f18 has been researched along with Bowel Diseases, Inflammatory in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (10.53) | 29.6817 |
| 2010's | 14 (73.68) | 24.3611 |
| 2020's | 3 (15.79) | 2.80 |
| Authors | Studies |
|---|---|
| Hustinx, R; Lovinfosse, P | 1 |
| Brodersen, JB; Hess, S | 1 |
| Hurme, S; Kauhanen, S; Kemppainen, J; Koffert, J; Kujari, H; Saunavaara, V; Tenhami, M; Teperi, S; Virtanen, J; Voutilainen, M | 1 |
| Horai, Y; Ichinose, K; Igawa, T; Kawakami, A; Kurushima, S; Nakamura, H | 1 |
| Dmochowska, N; Hughes, PA; Wardill, HR | 1 |
| Baker, A; Baumann, C; Choukour, M; Guillemin, F; Kivits, J; Peyrin-Biroulet, L | 1 |
| Laghi, A; Martin-Comin, J; Reinisch, W | 1 |
| Bernards, N; Boisgard, R; Dollé, F; Pottier, G; Thézé, B | 1 |
| Li, LF; Liu, NH; Qiu, H; Weng, WW; Xu, Q; Yang, J; Zhang, J; Zhu, YJ | 1 |
| Basu, S; Hansson, SH; Hess, S; Høilund-Carlsen, PF; Pedersen, KT | 1 |
| Das, CJ; Gupta, AK; Manchanda, S; Panda, A; Sharma, A | 1 |
| Abe, T; Fukunaga, S; Kaida, H; Kuwaki, K; Mitsuyama, K; Takedatsu, H; Torimura, T; Tsuruta, O; Yamasaki, H; Yamauchi, R; Yoshioka, S | 1 |
| Perlman, SB; Reichelderfer, M; Spier, BJ | 1 |
| Däbritz, J; Foell, D; Jasper, N; Loeffler, M; Weckesser, M | 1 |
| Ciarallo, A; Derbekyan, V; Makis, W | 1 |
| Akada, N; Enomoto, S; Higashikawa, K; Hiromura, M; Kamino, S; Kanayama, Y; Watanabe, K; Yagi, K | 1 |
| Bertagna, F; Caldarella, C; Cistaro, A; Fania, P; Farchione, A; Quartuccio, N; Sadeghi, R; Treglia, G | 1 |
| Bettinger, T; Bussat, P; Gambhir, SS; Luong, R; Lutz, AM; Machtaler, S; Tian, L; Tranquart, F; Wang, H; Willmann, JK | 1 |
| Franzius, C; Löffler, M; Schober, O; Weckesser, M; Zimmer, KP | 1 |
9 review(s) available for fluorodeoxyglucose f18 and Bowel Diseases, Inflammatory
| Article | Year |
|---|---|
The role of PET imaging in inflammatory bowel diseases: state-of-the-art review.
Topics: Artificial Intelligence; Fluorodeoxyglucose F18; Humans; Inflammatory Bowel Diseases; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2022 |
FDG-PET/CT in Inflammatory Bowel Disease: Is There a Future?
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Inflammatory Bowel Diseases; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2020 |
Advances in Imaging Specific Mediators of Inflammatory Bowel Disease.
Topics: Animals; Cytokines; Disease Models, Animal; Endoscopy, Gastrointestinal; Fluorodeoxyglucose F18; Gastrointestinal Microbiome; Gene Expression; Humans; Immunoglobulin G; Inflammatory Bowel Diseases; Integrins; Intestines; Mice; Positron-Emission Tomography; Rabbits; Tomography, Emission-Computed, Single-Photon | 2018 |
Common diagnostic flow charts for diagnosis and management of patients with an inflammatory bowel disease.
Topics: Congresses as Topic; Decision Support Systems, Clinical; Europe; Fluorodeoxyglucose F18; Humans; Inflammatory Bowel Diseases; Leukocytes; Magnetic Resonance Imaging; Nuclear Medicine; Positron-Emission Tomography; Radiopharmaceuticals; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2014 |
Diagnostic performance of 18F-FDG-PET versus scintigraphy in patients with inflammatory bowel disease: a meta-analysis of prospective literature.
Topics: Fluorodeoxyglucose F18; Humans; Inflammatory Bowel Diseases; Positron-Emission Tomography; Prospective Studies; Sensitivity and Specificity | 2014 |
FDG-PET/CT in Infectious and Inflammatory Diseases.
Topics: Arthritis, Rheumatoid; Bacterial Infections; Bone Diseases; Endocarditis; Fluorodeoxyglucose F18; Humans; Immunocompromised Host; Inflammation; Inflammatory Bowel Diseases; Multimodal Imaging; Positron-Emission Tomography; Psoriasis; Pulmonary Disease, Chronic Obstructive; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed; Vasculitis; Venous Thromboembolism | 2014 |
Recent Advances in Imaging of Small and Large Bowel.
Topics: Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Inflammatory Bowel Diseases; Intestinal Neoplasms; Magnetic Resonance Imaging; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
FDG-PET in inflammatory bowel disease.
Topics: Fluorodeoxyglucose F18; Humans; Incidental Findings; Inflammatory Bowel Diseases; Positron-Emission Tomography; Tomography, X-Ray Computed | 2009 |
Diagnostic performance of Fluorine-18-Fluorodeoxyglucose positron emission tomography in patients with chronic inflammatory bowel disease: a systematic review and a meta-analysis.
Topics: Area Under Curve; Chronic Disease; Confidence Intervals; Fluorodeoxyglucose F18; Humans; Inflammatory Bowel Diseases; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Tomography, X-Ray Computed | 2013 |
1 trial(s) available for fluorodeoxyglucose f18 and Bowel Diseases, Inflammatory
| Article | Year |
|---|---|
A longitudinal study of FDG-PET in Crohn disease patients receiving granulocyte/monocyte apheresis therapy.
Topics: Adolescent; Adult; Blood Component Removal; Crohn Disease; Female; Fluorodeoxyglucose F18; Granulocytes; Humans; Inflammatory Bowel Diseases; Longitudinal Studies; Male; Middle Aged; Monocytes; Positron-Emission Tomography; Young Adult | 2016 |
9 other study(ies) available for fluorodeoxyglucose f18 and Bowel Diseases, Inflammatory
| Article | Year |
|---|---|
The value of combined positron emission tomography/magnetic resonance imaging to diagnose inflammatory bowel disease: a prospective study.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Inflammatory Bowel Diseases; Magnetic Resonance Imaging; Male; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Young Adult | 2021 |
[Coexistence of Takayasu's arteritis and inflammatory colitis detected by fluorodeoxyglucose positron emission tomography].
Topics: Adult; Colitis; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Inflammatory Bowel Diseases; Positron-Emission Tomography; Prednisolone; Radiopharmaceuticals; Sensitivity and Specificity; Takayasu Arteritis; Treatment Outcome; Vulnerable Populations | 2017 |
Personalised medicine in inflammatory bowel diseases: a patient survey.
Topics: Crohn Disease; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Inflammatory Bowel Diseases; Pilot Projects; Positron Emission Tomography Computed Tomography; Precision Medicine; Prognosis; Surveys and Questionnaires | 2019 |
In vivo evaluation of inflammatory bowel disease with the aid of μPET and the translocator protein 18 kDa radioligand [18F]DPA-714.
Topics: Animals; Colon; Dextran Sulfate; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gamma Rays; Glucose; Image Processing, Computer-Assisted; Immunohistochemistry; Inflammation; Inflammatory Bowel Diseases; Ligands; Male; Positron-Emission Tomography; Pyrazoles; Pyrimidines; Rats; Rats, Wistar; Trinitrobenzenesulfonic Acid | 2015 |
Noninvasive assessment of pediatric inflammatory bowel disease with ¹⁸F-fluorodeoxyglucose-positron emission tomography and computed tomography.
Topics: Adolescent; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Inflammatory Bowel Diseases; Male; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 2011 |
Primary peripheral T-cell lymphoma of the colon mimics inflammatory bowel disease: a potential pitfall with F-18 FDG PET/CT imaging.
Topics: Colon; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Inflammatory Bowel Diseases; Lymphoma, T-Cell, Peripheral; Positron-Emission Tomography; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |
Exploration of target molecules for molecular imaging of inflammatory bowel disease.
Topics: Animals; Biomarkers; Colon; Cytokines; Dextran Sulfate; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Indomethacin; Inflammatory Bowel Diseases; Mice; Mice, Inbred BALB C; Positron-Emission Tomography; Receptors, Cytokine | 2011 |
Molecular imaging of inflammation in inflammatory bowel disease with a clinically translatable dual-selectin-targeted US contrast agent: comparison with FDG PET/CT in a mouse model.
Topics: Analysis of Variance; Animals; Contrast Media; Disease Models, Animal; E-Selectin; Fluorodeoxyglucose F18; Immunoglobulin G; Inflammatory Bowel Diseases; Mice; Mice, Inbred BALB C; Molecular Imaging; Multimodal Imaging; P-Selectin; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Ultrasonography | 2013 |
High diagnostic value of 18F-FDG-PET in pediatric patients with chronic inflammatory bowel disease.
Topics: Adolescent; Child; Child, Preschool; Crohn Disease; Endoscopy, Gastrointestinal; Female; Fluorodeoxyglucose F18; Humans; Inflammatory Bowel Diseases; Male; Positron-Emission Tomography; Radiopharmaceuticals | 2006 |